Seagen Inc 's Revenue in the fiscal year 2022 $ 1,962.41 millions
Seagen Inc 's Revenue in the fiscal year 2021 $ 1,574.37 millions
Seagen Inc 's Revenue in the fiscal year 2020 $ 2,175.54 millions
Seagen Inc 's Revenue in the fiscal year 2019 $ 916.71 millions
Seagen Inc 's Revenue in the fiscal year 2018 $ 654.70 millions
SGEN Revenue third quarter 2023 Y/Y Growth Comment
Seagen Inc reported Revenue improvement of 27.11% year on year in the third quarter 2023, to $ 648.65 millions, this is lower than Seagen Inc 's recent average Revenue rise of 49.61%.
Looking into third quarter 2023 results within Biotechnology & Pharmaceuticals industry 19 other companies have achieved higher Revenue growth. While Seagen Inc ' s Revenue rise of 27.11% ranks overall at the positon no. 669 in the third quarter 2023.
Revenue by Quarter for the Fiscal Years 2020, 2021, 2022, 2023
Seagen Inc 's Q/Q Revenue Growth
Revenue Q/Q Growth Statistics
High
Average
Low
281.92 %
10.98 %
-56.64 %
(Sep 30 2020)
SGEN's III. Quarter Q/Q Revenue Comment
Seagen Inc achieved in the III. Quarter 2023 below company average Revenue increase of 7.42% quarter on quarter, to $ 648.65 millions.
III. Quarter 2023 Revenue Q/Q growth were paradoxical, although lower than the regular, yet it demonstrates absolute recovery measured to the 2.57% in the III. Quarter a year ago.
Within Biotechnology & Pharmaceuticals industry 46 other companies have achieved higher Revenue quarter on quarter growth. While Seagen Inc 's Revenue growth quarter on quarter, overall rank is 1141.
Seagen Inc achieved in the III. Quarter 2023 below company average Revenue increase of 7.42% quarter on quarter, to $ 648.65 millions.
III. Quarter 2023 Revenue Q/Q growth were paradoxical, although lower than the regular, yet it demonstrates absolute recovery measured to the 2.57% in the III. Quarter a year ago.
Within Biotechnology & Pharmaceuticals industry 46 other companies have achieved higher Revenue quarter on quarter growth. While Seagen Inc 's Revenue growth quarter on quarter, overall rank is 1141.
Seagen Inc 's 12 Months Revenue Growth Year on Year
Revenue TTM Growth
12 Months Ending (Sep 30 2023)
12 Months Ending (Jun 30 2023)
12 Months Ending (Mar 31 2023)
12 Months Ending (Dec 31 2022)
12 Months Ending (Sep 30 2022)
Cumulative Revenue 12 Months Ending
$ 2,300.35
$ 2,162.00
$ 2,055.67
$ 1,962.41
$ 1,864.11
Y / Y Revenue Growth (TTM)
23.4 %
21.61 %
23.18 %
24.65 %
6.78 %
Year on Year Revenue Growth Overall
Ranking
# 1647
# 744
# 3346
# 2213
# 270
Seqeuential Revenue Change (TTM)
6.4 %
5.17 %
4.75 %
5.27 %
4.85 %
Seq. Revenue Growth (TTM) Overall
Ranking
# 1812
# 431
# 2078
# 2062
# 96
Cumulative Revenue growth Comment
Although Seagen Inc 's Annual Revenue growth year on year were below company's average 29.35% , Revenue announced in the Sep 30 2023 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 23.4% year on year, from 21.61% in Jun 30 2023.
In the Healthcare sector 292 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 744 to 1647.
Although Seagen Inc 's Annual Revenue growth year on year were below company's average 29.35% , Revenue announced in the Sep 30 2023 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 23.4% year on year, from 21.61% in Jun 30 2023.
In the Healthcare sector 292 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 744 to 1647.
About Seagen Inc Revenue Growth Rates (SGEN), Current and Historic Growth - CSIMarket Analysis
How we calculate this
This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years).
Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
45.97%